/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. AI For Pharma Growth
  2. E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026
E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

AI For Pharma Growth · Aug 4, 2026

From reactive paper-chaser to proactive quality guardian: how technology can free up 40% of a Pharma QP's time for high-value work.

Pharma QPs Lose 40% of Their Time to Administrative Tasks That Technology Can Automate

A Qualified Person's (QP) role is dominated by administrative work, not critical decision-making. Systems that make information discoverable can cut this admin time by 30%. An additional 10-15% can be saved by automating basic checks for batch numbers, dates, and versions, freeing QPs for high-value risk analysis.

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 thumbnail

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

AI For Pharma Growth·2 days ago

To Drive AI Adoption in Pharma, First Distinguish It From Decades-Old Tech Like OCR

Gaining buy-in for AI in the risk-averse pharma industry requires demystification. Leaders should educate stakeholders that many perceived 'AI' functions are actually established technologies like Optical Character Recognition (OCR) or simple database pre-filling. This approach separates advanced AI from basic automation, easing fears about reliability and 'hallucinations'.

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 thumbnail

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

AI For Pharma Growth·2 days ago

Pharma Batch Release Delays Stem from Documentation Review, Not Physical Logistics

When inquiring about a batch's status, leadership often incorrectly focuses on its physical location. The real bottleneck causing delays is the documentation lifecycle—waiting for documents to arrive, verifying their accuracy, and completing reviews. A batch can be physically ready in a warehouse but unable to be released due to pending paperwork.

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 thumbnail

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

AI For Pharma Growth·2 days ago

Effective AI for QPs Involves Digitizing and Perpetuating Their Unique Expertise

The future role of a Qualified Person (QP) shifts from repetitive checking to designing automated checks. When a QP identifies a new edge case or potential risk, they can digitize that specific check. This allows their unique expertise to be run automatically and perpetually on all future batches, continuously scaling their impact and enhancing patient safety.

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 thumbnail

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

AI For Pharma Growth·2 days ago

A QP's 'Aha!' Moment with New Tech Is Escaping the Mailbox, Not Complex AI Features

The most significant initial impact for a Qualified Person adopting a new platform is not a sophisticated feature, but the simple relief from 'fighting their mailbox.' By centralizing tasks and communication, the system eliminates the constant psychological drain of email and other messaging apps, allowing for focused work on batch release.

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 thumbnail

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

AI For Pharma Growth·2 days ago

The Future of Pharma Audits May Involve Real-Time, Collaborative AI-Powered Guidance

Regulatory oversight is poised to shift from punitive, after-the-fact audits to a collaborative model. AI systems could provide a standardized, real-time audit report accessible to both the manufacturer and the regulator. This transparency allows for proactive issue resolution, with regulators acting as guides rather than just enforcers.

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 thumbnail

E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026

AI For Pharma Growth·2 days ago